Advanced search
Publication Cover
Infection and Drug Resistance Volume 15, 2022 - Issue
Submit an article Journal homepage
140
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Evaluating the Response and Safety of Inactivated COVID-19 Vaccines in Liver Transplant Recipients

Zhen-Hua Tu1 Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-1627-3404
ORCID Icon,
Ping-Bo Jin1 Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-5540-7014
ORCID Icon,
Di-Yu Chen1 Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People’s Republic of China
,
Zhi-Yun Chen1 Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People’s Republic of China
,
Zhi-Wei Li1 Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People’s Republic of China
,
Jie Wu2 State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Hangzhou, 310003, People’s Republic of China
,
Bin Lou3 Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People’s Republic of China
,
Bao-Shan Zhang4 Department of Nursing, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People’s Republic of China
,
Lin Zhang1 Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People’s Republic of China
,
Wei Zhang1 Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People’s Republic of China
&
Ting-Bo Liang1 Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People’s Republic of China;5 Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People’s Republic of China;6 Zhejiang Province Innovation Center for the Study of Pancreatic Diseases, Hangzhou, 310003, People’s Republic of China;7 Zhejiang University Cancer Center, Hangzhou, 310003, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 2469-2474 | Published online: 12 May 2022

References

  • Emmie de W, Neeltje van D, Darryl F, et al. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523–534. doi:10.1038/nrmicro.2016.81
  • Kim KH, Tandi TE, Choi JW, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. J Hosp Infect. 2017;95(2):207–213. doi:10.1016/j.jhin.2016.10.008
  • World Health Organization. Coronavirus disease (COVID-19) pandemic; 2022. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed May 10, 2022.
  • Zhang XY, Guo J, Wan X, et al. Biochemical and antigenic characterization of the structural proteins and their posttranslational modifications in purified SARS-CoV-virions of an inactivated vaccine candidate. Emerg Microbes Infect. 2020;9(1):2653–2662. doi:10.1080/22221751.2020.1855945
  • Rabinowich L, Grupper A, Baruch R, et al. Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients. J Hepatol. 2021;75(2):435–438. doi:10.1016/j.jhep.2021.04.020
  • Benotmane I, Gautier-Vargas G, Cognard N, et al. Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients. Kidney Int. 2021;99(6):1487–1489. doi:10.1016/j.kint.2021.03.014
  • Zhang YJ, Zeng G, Pan HX, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomized, double-blind, placebo-controlled, Phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(2):181–192. doi:10.1016/S1473-3099(20)30843-4
  • Azzi Y, Bartash R, Scalea J, et al. COVID-19 and solid organ transplantation: a review article. Transplantation. 2021;105(1):37–55. doi:10.1097/TP.0000000000003523
  • Azzi Y, Parides M, Alani O, et al. COVID-19 infection in kidney transplant recipients at the epicenter of pandemics. Kidney Int. 2020;98(6):1559–1567. doi:10.1016/j.kint.2020.10.004
  • Dumortier J, Duvoux C, Roux O, et al. COVID-19 in liver transplant recipients: the French SOT COVID registry. Clin Res Hepatol Gastroenterol. 2021;45(4):101639. doi:10.1016/j.clinre.2021.101639
  • Grupper A, Rabinowich L, Schwartz D, et al. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus. Am J Transplant. 2021;21(8):2719–2726. doi:10.1111/ajt.16615

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.